<code id='ABAA8439C0'></code><style id='ABAA8439C0'></style>
    • <acronym id='ABAA8439C0'></acronym>
      <center id='ABAA8439C0'><center id='ABAA8439C0'><tfoot id='ABAA8439C0'></tfoot></center><abbr id='ABAA8439C0'><dir id='ABAA8439C0'><tfoot id='ABAA8439C0'></tfoot><noframes id='ABAA8439C0'>

    • <optgroup id='ABAA8439C0'><strike id='ABAA8439C0'><sup id='ABAA8439C0'></sup></strike><code id='ABAA8439C0'></code></optgroup>
        1. <b id='ABAA8439C0'><label id='ABAA8439C0'><select id='ABAA8439C0'><dt id='ABAA8439C0'><span id='ABAA8439C0'></span></dt></select></label></b><u id='ABAA8439C0'></u>
          <i id='ABAA8439C0'><strike id='ABAA8439C0'><tt id='ABAA8439C0'><pre id='ABAA8439C0'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:8
          Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT
          Adobe

          Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

          The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

          advertisement

          The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Biogen Alzheimer’s drug launch off to slow start
          Biogen Alzheimer’s drug launch off to slow start

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPSevenmonthsafterUSdrugregulatorsfullyapprovedBiogen’stre

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Vaccine advisory panel ACIP left half staffed by HHS

          ACIP,normallya15-memberpanel,haseightvacancies,andfourmorecomingsoon.Whyhasn'tHHSsignedoffontheCDC's